April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Morphometry of retinal arterioles after initiation of hypotensive treatment: an adaptive optics imaging study.
Author Affiliations & Notes
  • Edouard Koch
    Clinical Investigation Center, Quinze-Vingts Hospital-INSERM, Paris, France
    Ophthalmology, CH Andre Mignot, Versailles, France
  • David Rosenbaumm
    Cardiology, Pitié Salpétrière Hospital, Paris, France
  • Florence Rossant
    Institut Supérieur d, ISEP, Paris, France
  • Jose Alain Sahel
    Clinical Investigation Center, Quinze-Vingts Hospital-INSERM, Paris, France
  • Xavier Girerd
    Cardiology, Pitié Salpétrière Hospital, Paris, France
  • Michel Paques
    Clinical Investigation Center, Quinze-Vingts Hospital-INSERM, Paris, France
  • Footnotes
    Commercial Relationships Edouard Koch, None; David Rosenbaumm, None; Florence Rossant, None; Jose Sahel, None; Xavier Girerd, None; Michel Paques, MerckSerono (C), Roche (C), Sanofi (E)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 2603. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Edouard Koch, David Rosenbaumm, Florence Rossant, Jose Alain Sahel, Xavier Girerd, Michel Paques; Morphometry of retinal arterioles after initiation of hypotensive treatment: an adaptive optics imaging study.. Invest. Ophthalmol. Vis. Sci. 2014;55(13):2603.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Morphological changes affecting small retinal arteries are a surrogate of end-organ damage. Fine details of microvascular morphometry can be observed I the retina using adaptive optics (AO) near infrared (NIR) imaging (Koch et al, J Hypertens. in press). Here we investigated the changes of the diameter of retinal arterioles (50-150 μm diameter) in hypertensive humans after initiation of hypotensive treatment.

Methods: In a group of hypertensive subjects (n = 9; mean 52.33 years [range, 42;66] mean systolic pressure 137.2 [range, 111;177]) the inner diameter (ID) of the superotemporal artery was measured by OA imaging (rtx1; ImagineEyes, France) using a custom software. The changes in ID before and after initiation of hypotensive treatment (calcium channel blocker, beta blocker, angiotensin receptor antagonist) were analyzed.

Results: The mean follow-up was125 days [range, 48-258]. The ID showed a nonsignificant increase after initiation of hypotensive treatment patients although the observed effect varied greatly between subjects (average increase 3.4%; range, -0.5% to 10.9%). Blood pressure variations or treatment type were not correlated to variations of ID.

Conclusions: The vasodilatory effect of hypotensive drugs can be measured in vivo using AO imaging. Hypotensive treatment induces variable changes in the diameter of small retinal arteries. The absence of correlation with blood pressure changes suggest that microvascular responses are independant biomakers of the effect of vasodilatory treatment and hence may be a parameter of interest for evaluating the risk of end-organ damage. Future studies on larger cohorts are ongoing.

Keywords: 550 imaging/image analysis: clinical • 503 drug toxicity/drug effects • 688 retina  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×